COGT
Price
$7.76
Change
+$0.19 (+2.51%)
Updated
May 7, 6:59 PM EST
Earnings call today
KROS
Price
$58.68
Change
-$1.58 (-2.62%)
Updated
May 7, 6:59 PM EST
86 days until earnings call
Ad is loading...

COGT vs KROS

Header iconCOGT vs KROS Comparison
Open Charts COGT vs KROSBanner chart's image
Cogent Biosciences
Price$7.76
Change+$0.19 (+2.51%)
Volume$427.81K
CapitalizationN/A
Keros Therapeutics
Price$58.68
Change-$1.58 (-2.62%)
Volume$94.71K
CapitalizationN/A
View a ticker or compare two or three
COGT vs KROS Comparison Chart

Loading...

COGTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
KROSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
COGT vs. KROS commentary
May 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and KROS is a Hold.

COMPARISON
Comparison
May 07, 2024
Stock price -- (COGT: $7.53 vs. KROS: $60.57)
Brand notoriety: COGT and KROS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 53% vs. KROS: 166%
Market capitalization -- COGT: $723.79M vs. KROS: $2.17B
COGT [@Biotechnology] is valued at $723.79M. KROS’s [@Biotechnology] market capitalization is $2.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $547.77B to $0. The average market capitalization across the [@Biotechnology] industry is $2.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileKROS’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • KROS’s FA Score: 0 green, 5 red.
According to our system of comparison, both COGT and KROS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 7 TA indicator(s) are bullish while KROS’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 7 bullish, 2 bearish.
  • KROS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, COGT is a better buy in the short-term than KROS.

Price Growth

COGT (@Biotechnology) experienced а +25.08% price change this week, while KROS (@Biotechnology) price change was +4.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.06%. For the same industry, the average monthly price growth was -3.25%, and the average quarterly price growth was +71.73%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2024.

KROS is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+4.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for COGT with price predictions.
OPEN
A.I.dvisor published
a Summary for KROS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
KROS($2.17B) has a higher market cap than COGT($724M). KROS YTD gains are higher at: 52.339 vs. COGT (28.061).
COGTKROSCOGT / KROS
Capitalization724M2.17B33%
EBITDAN/AN/A-
Gain YTD28.06152.33954%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COGTKROS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 15 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
COGTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
KROSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMXKX7.260.08
+1.11%
Federated Hermes Max-Cap Index R
BIAVX15.090.13
+0.87%
Brown Advisory Beutel GoodmanLg-CpValInv
DCUIX13.640.11
+0.81%
DWS CROCI US Inst
NBPBX43.500.11
+0.25%
Neuberger Berman Large Cap Value Adv
FVLIX22.380.05
+0.22%
Fidelity Advisor Value Leaders I

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SNDX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SNDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+3.29%
SNDX - COGT
51%
Loosely correlated
+0.87%
BMEA - COGT
44%
Loosely correlated
+3.52%
KROS - COGT
42%
Loosely correlated
+6.08%
DSGN - COGT
39%
Loosely correlated
+1.92%
XFOR - COGT
37%
Loosely correlated
+6.48%
More

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with XNCR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+6.08%
XNCR - KROS
45%
Loosely correlated
+2.03%
AXON - KROS
43%
Loosely correlated
+0.57%
VTYX - KROS
43%
Loosely correlated
-1.22%
DYN - KROS
42%
Loosely correlated
+0.31%
COGT - KROS
42%
Loosely correlated
+3.29%
More